OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RNA Sequencing of Hepatobiliary Cancer Cell Lines: Data and Applications to Mutational and Transcriptomic Profiling
Dominique Scherer, Marcela Dávila López, Benjamin Goeppert, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2510-2510
Open Access | Times Cited: 7
Dominique Scherer, Marcela Dávila López, Benjamin Goeppert, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2510-2510
Open Access | Times Cited: 7
Showing 7 citing articles:
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F. Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 462-480
Open Access | Times Cited: 23
Diego F. Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 462-480
Open Access | Times Cited: 23
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
Mikel Ruiz de Gauna, Francesca Biancaniello, Francisco González‐Romero, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1617-1633
Open Access | Times Cited: 29
Mikel Ruiz de Gauna, Francesca Biancaniello, Francisco González‐Romero, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1617-1633
Open Access | Times Cited: 29
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
Michael J. Viereckl, Kelsey Krutsinger, Aaron K. Apawu, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 854-854
Open Access | Times Cited: 25
Michael J. Viereckl, Kelsey Krutsinger, Aaron K. Apawu, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 854-854
Open Access | Times Cited: 25
Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progression
Eleonora Vitali, Barbara Franceschini, Flavio Milana, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 518-531
Open Access | Times Cited: 5
Eleonora Vitali, Barbara Franceschini, Flavio Milana, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 518-531
Open Access | Times Cited: 5
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids
Adriana Romanzi, Fabiola Milosa, Gemma Marcelli, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 87-87
Open Access | Times Cited: 4
Adriana Romanzi, Fabiola Milosa, Gemma Marcelli, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 87-87
Open Access | Times Cited: 4
Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts
Alice Blandino, Dominique Scherer, Felix Boekstegers, et al.
European Journal of Cancer (2024) Vol. 214, pp. 115138-115138
Open Access
Alice Blandino, Dominique Scherer, Felix Boekstegers, et al.
European Journal of Cancer (2024) Vol. 214, pp. 115138-115138
Open Access
Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways
Chia-Hung Hsu, Pei‐Wei Weng, Ming‐Yao Chen, et al.
Chemico-Biological Interactions (2022) Vol. 370, pp. 110329-110329
Closed Access | Times Cited: 1
Chia-Hung Hsu, Pei‐Wei Weng, Ming‐Yao Chen, et al.
Chemico-Biological Interactions (2022) Vol. 370, pp. 110329-110329
Closed Access | Times Cited: 1
